Press Releases

Summary ToggleProLungdx Showcases its EPN Scan® for Lung Cancer at the White Hat Investors Conference

September 07, 2016

Salt Lake City, UT, USA, September 7, 2016 –  ProLungdx™ today announced plans to present its ground-breaking innovation for lung cancer patients at the AZBIO’s 2016 White Hat Life Science Investors Conference in Phoenix, Arizona September 21 and 22, 2016.

Summary ToggleUniversity of Liverpool Lung Cancer Research

June 04, 2016

Lung cancer survival rate increases by 73% if caught early. A major lung cancer screening trial, conducted by experts at the University of Liverpool, has found that patients with a high risk of developing lung cancer can be identified with early stage disease and have up to a 73% chance

Summary ToggleProLungdx Board Names Dr. John C. Ruckdeschel as Newest Board Member

May 26, 2016

Salt Lake City, Utah, May 25, 2016 –  The Board of Directors of Fresh Medical Laboratories Inc., doing business as ProLungdx, today announced the appointment of Dr. John C. Ruckdeschel, M.D. to serve as a Director on the Company’s Board of Directors.  Dr.

Summary ToggleProLungdx Announces Todd Morgan as Chairman of the Board

May 19, 2016

Salt Lake City, Utah, May 19, 2016 –  Fresh Medical Laboratories, Inc, doing business as ProLungdx™, announced today that its board has appointed Todd Morgan as Chairman of the Board of Directors.  Mr. Morgan succeeds Clark Campbell, who served as the Chairman from 2012 to 2016.

Summary ToggleProLungdx EPN Scan® Confirms Performance in Early Lung Cancer Risk Assessment

May 18, 2016

ProLungdx EPN Scan® Confirms Performance in Early Lung Cancer Risk Salt Lake City, Utah, USA, May 18, 2016 –  Fresh Medical Laboratories, Inc., doing business as ProLungdx™, today announced the initial results of its ongoing European Lung Cancer Registry.